Clinical Evidence: Anxiety Risk on GLP-1 Receptor Agonists Major semaglutide trials, including STEP and SUSTAIN programs, reported anxiety in fewer than 3% of treatment participantsrates comparable to placebo control groups
For many people, a daily pill feels more approachable and accessible than an injection
This step ensures accurate dosing
Repeatedly injecting into the same site can cause increased pain and bruising
Current projects include micro-injection devices for ocular injections, low-dead-space safety needles and syringes, auto-retractable syringes that self-destruct once the injection is delivered, and glass syringes that allow for the drug and the delivery system to be combined into one device
Whether the goal is to workout more, eat more veggies, or reduce screen time, things take time